Prospective evaluation of sacubitril/valsartan utilization patterns and clinical outcomes in Korean patients with heart failure with reduced ejection fraction: real-world post-marketing surveillance
13 May 2024 (14:00 - 15:00)
Organised by: 
About the speaker
Samsung Medical Center, Seoul (Korea (Republic of))
5 More presentations in this session
Assistant Professor A. Lacraru (Bucharest, RO)
Professor A. Safarova (Baku, AZ)
Doctor A. Ferreira (Lisbon, PT)
Doctor P. Tolomeo (Glasgow, GB)
Access the full session
The Event
Heart Failure 2024
13 May 2024
14:00 CET
You may be interested in
Congress Presentation
